Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Ask the chart: “Has this stock recovered from similar drawdowns before?”
AI equity note (bull/bear, numbers, sources) — coming soon
Management guidance consistency — coming soon
Latest filings
NSE announcements · newest firstKey MetricsFull financials →
P/E (TTM)
-35.2×
EPS ₹-8.19
P / Book
1.43×
BVPS ₹201
ROE
-0.2%
FY26, avg equity
Net margin
-0.1%
FY26
Revenue YoY
+49.7%
Q1 FY27
Net profit YoY
−92.5%
Q1 FY27
Debt / equity
0.03×
₹22 Cr debt
Div. yield
–
no dividend in 12 months
From NSE filings (consolidated) and the last close.
Shareholding Pattern Jun 2026
Promoter pledge: none reported
Peer Comparison
| Company | P/E | P/B | ROE | Margin |
|---|---|---|---|---|
| THYROCARE₹9,023 Cr | 51.3× | 15.41× | 28.8% | 19.6% |
| NEPHROPLUS₹6,990 Cr | – | 6.26× | 6.9% | 7.7% |
| SURAKSHA₹1,788 Cr | 49.7× | 7.30× | 13.8% | 10.1% |
| KRSNAA₹1,779 Cr | 18.3× | 1.81× | 10.9% | 13.1% |
| HEALTHX₹918 Cr | – | 1.43× | -0.2% | -0.1% |
| GAUDIUMIVF₹839 Cr | – | 5.51× | 16.1% | 23.4% |
Healthcare Service Provider: the companies closest in market value, of the 9 in that basic industry whose filings we hold. Computed from each company's NSE filings (up to Q1 FY27) and the last close; hover a column for its definition.
Forensic Flags4 Watch
Free cash flow was negative in 3 of the last 4 years
Operating cash flow less capital expenditure, as filed.
Profit before interest and tax covers finance costs -2.0×
FY26.
Exceptional items above 5% of pre-tax profit in 3 of the last 5 years
FY21–FY26.
Results were filed late in 2 of the last 8 quarters
Slowest filing came 60 days after the period end.
6 checks within their thresholds
Inventory grew 31% against revenue growth of 19%
FY26: inventory days moved from 36 to 40.
Debt to equity is 0.03×
As at 2026-03-31; it was 0.00× at 2023-03-31.
Share count changed +0.0% in three years, net of bonuses and splits
From 2023-03-31 to 2026-03-31. Shares issued for mergers, placements, conversions and stock options all count.
Promoter holding is 74.07%, -0.17 points over a year
2026-06-30 against 2025-06-30.
No promoter shares are pledged
Shareholding pattern as at 2026-06-30.
No auditor change or resignation filings in three years
From NSE announcements on record.
Computed from NSE filings (consolidated). Colours follow fixed thresholds, shown on hover. These are facts about the filings, not advice. 1 check not run for lack of data.
Formula Scores
Piotroski F-score: 4 of 9 · FY to 2026-03-31one point for each of nine tests on profitability, leverage and liquidity, and operating efficiency, comparing the year with the one before
- ✗ Return on assets positive: -0.15 — profit after tax over the year's opening total assets, %
- ✗ Operating cash flow positive: -73.8 — ₹ crore
- ✗ Cash flow above profit (accruals): -72.4 — operating cash flow less profit after tax, ₹ crore
- ✓ Return on assets improved: 11.47 — change in ROA, percentage points
- ✗ Long-term borrowings to assets fell: 2.36 — change in long-term borrowings over total assets, percentage points
- Current ratio improved — current assets or liabilities not broken out
- ✓ No new shares issued: 0 — change in share capital, %
- ✓ Gross margin improved: 0.1 — revenue less material cost over revenue, change in percentage points
- ✓ Asset turnover improved: 0.388 — revenue over the year's opening total assets, change
Inputs: profit after tax ₹-1 Cr (2026-03-31) · profit after tax ₹-134 Cr (2025-03-31) · total assets ₹936 Cr (2026-03-31) · total assets ₹974 Cr (2025-03-31)
The paper's bands: 8–9: the paper's high group; 0–2: the paper's low group
8 of the nine tests could be run; the score counts the ones that passed
Source: Joseph Piotroski, "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers", Journal of Accounting Research, 2000
Altman Z-score: not computed · FY to 2026-03-31needs total and current assets, current liabilities, reserves, equity, profit before tax and revenue
Graham number: 40.95 ₹ per share · FY to 2026-03-31√(22.5 × earnings per share × book value per share): the price at which P/E × P/B = 22.5 (a P/E of 15 at a P/B of 1.5)
- earnings per share: 0.37
- book value per share: 201.47 — owners' equity over shares (paid-up capital / face value)
Inputs: earnings per share 0.37 (2026-03-31) · owners' equity ₹641 Cr (2026-03-31) · paid-up capital ₹32 Cr (2026-03-31) · face value 10 (2026-03-31)
a number the book uses as a ceiling for a defensive investor's purchase price; it is arithmetic on two reported figures, not a valuation
Source: Benjamin Graham, The Intelligent Investor (1949; the 22.5 in the 1973 edition's criteria for the defensive investor)
Sloan accrual ratio: 7.58 % of assets · FY to 2026-03-31(profit after tax − operating cash flow) / average total assets
Inputs: profit after tax ₹-1 Cr (2026-03-31) · operating cash flow ₹-74 Cr (2026-03-31) · total assets ₹936 Cr (2026-03-31) · total assets ₹974 Cr (2025-03-31)
how much of the year's profit was not cash; the paper sorts companies by this and reports the top decile's later returns
Source: Richard Sloan, "Do Stock Prices Fully Reflect Information in Accruals and Cash Flows about Future Earnings?", The Accounting Review, 1996
Each score is its published formula applied to the company's own filings (consolidated); open one for the tests, the inputs and the paper. Arithmetic on the filings, not a view on the stock.